Lateral flow immunoassays (LFIAs) are a staple in the field of rapid diagnostics. These small handheld devices require no specialized training or equipment to operate, and generate a result within minutes of sample application. They are an ideal format for many types of home test kits, for emergency responders and for food manufacturers and producers looking for a quick evaluation of a given sample. LFIAs rely on high quality monoclonal antibodies that recognize the analyte of interest. As monoclonal antibody technology becomes more accessible to smaller laboratories, there has been increased interest in developing LFIA prototypes for potential commercial manufacture. In this chapter, the basics of designing and building an LFIA prototype are described.
[1]
Kathryn H Ching,et al.
Rapid and selective detection of botulinum neurotoxin serotype-A and -B with a single immunochromatographic test strip.
,
2012,
Journal of immunological methods.
[2]
Geertruida A. Posthuma-Trumpie,et al.
Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey
,
2009,
Analytical and bioanalytical chemistry.
[3]
S. Yokota.
Preparation of colloidal gold particles and conjugation to protein A, IgG, F(ab')(2), and streptavidin.
,
2010,
Methods in molecular biology.
[4]
Brendan O’Farrell,et al.
Evolution in Lateral Flow–Based Immunoassay Systems
,
2008,
Lateral Flow Immunoassay.